A phase III clinical trial to study the safety and efficacy of MK-1293 Compared to Lantus in Subjects with Type 2 diabetes Mellitus

  • Simpson, Richard (Primary Chief Investigator (PCI))
  • Gerstman, Murray, (Chief Investigator (CI))

Project: Research

StatusFinished
Effective start/end date26/08/1331/12/13